Medacta Group SA (LON:0A05)
London · Delayed Price · Currency is GBP · Price in CHF 147.20
-0.20 (-0.13%)
Feb 12, 2026, 4:31 PM GMT
Medacta Group Market Cap
Medacta Group has a market cap or net worth of 2.8 billion as of February 12, 2026. Its market cap has increased by 42.99% in one year.
Market Cap
2.80B
Enterprise Value
3.00B
Revenue
553.81M
Ranking
n/a
PE Ratio
34.44
Stock Price
147.20
Market Cap Chart
Since April 4, 2019, Medacta Group's market cap has increased from 1.47B to 2.80B, an increase of 90.49%. That is a compound annual growth rate of 9.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.79B | -4.62% |
| Dec 30, 2025 | 2.93B | 56.28% |
| Dec 30, 2024 | 1.87B | -19.82% |
| Dec 29, 2023 | 2.34B | 26.53% |
| Dec 30, 2022 | 1.85B | -19.74% |
| Dec 30, 2021 | 2.30B | 57.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.68B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| Convatec Group | 4.37B |
| Hikma Pharmaceuticals | 3.43B |
| Genus | 2.09B |
| HUTCHMED (China) | 1.88B |